Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

41.80
+0.03500.08%
Volume:16.82K
Turnover:705.40K
Market Cap:6.65B
PE:-13.94
High:42.21
Open:41.97
Low:41.72
Close:41.76
Loading ...

Ionis Pharmaceuticals Inc: Sees 2025 Revenue Above $600 Mln

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Inc Q4 Shr View $-1.12 -- Lseg Ibes Data

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Inc FY2025 REV View $675.9 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Inc Qtrly Shr Loss $0.66

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Q4 2024 GAAP EPS $(0.66) Beats $(1.10) Estimate, Sales $227.00M Beat $137.60M Estimate

Benzinga
·
19 Feb

BRIEF-Ionis Pharmaceuticals Q4 Revenue USD 227 Million Vs. IBES Estimate USD 137.6 Million

Reuters
·
19 Feb

Ionis Pharmaceuticals Q4 Operating Income USD -110 Million

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Q4 Adjusted Operating Expenses USD 301 Million

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Q4 Adjusted Operating Income USD -74 Million VS. Ibes Estimate USD -176.5 Million

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Q4 Operating Expenses USD 337 Million

THOMSON REUTERS
·
19 Feb

Exploring Analyst Estimates for Ionis Pharmaceuticals (IONS) Q4 Earnings, Beyond Revenue and EPS

Zacks
·
17 Feb

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
12 Feb

Why Insiders Are Selling Ionis Pharmaceuticals, Inc. (IONS) Recently

Insider Monkey
·
12 Feb

Ionis Pharmaceuticals Says Data Readout From Pelacarsen Study Is Delayed

MT Newswires Live
·
01 Feb

Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker

Blockhead
·
31 Jan

Ionis ‘remains confident in pelacarsen’ after Novartis update on Phase 3 timing

TIPRANKS
·
31 Jan

FDA & EMA Accept Biogen's Filings for Higher Dose SMA Drug

Zacks
·
24 Jan

Biogen Gets U.S., European Reviews of Higher-Dose Spinraza

Dow Jones
·
23 Jan

Biogen Gets FDA, EMA Approval to Study Higher Dose Regimen of Spinal Muscular Atrophy Treatment

MT Newswires Live
·
23 Jan

FDA and Ema Accept Applications for Higher Dose Regimen of Nusinersen in Sma

THOMSON REUTERS
·
23 Jan